Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB · BSE: 532305 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹392.50
Market cap: ₹3,413 Cr
Revenue (annual): ₹641.3 Cr
Net profit (annual): ₹41.42 Cr
P/E (TTM): 59.5×Sector 47.4×
Promoter holding: 42.93%-0.06% QoQ
FII holding: 10.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Capital Structure Change 6 Annual General Meeting 6 Price Movement Clarification 3 Financial Results 3 Board Meeting Date 3 Employee Stock Options 2 Capacity Expansion 2 Results Update 1 Management Change 1 Fund Raise 1 Earnings Call 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

10 Aug 2026 19:09 IST BSE

Financial ResultsAlfa Alert

Ind-Swift Laboratories Q1 FY27 Results: Net Profit ₹24.7 Cr, Up 180.7% YoY

Ind-Swift Laboratories Ltd reported revenue from operations of ₹191.5 Cr (+21.0% YoY) and net profit of ₹24.7 Cr (+180.7% YoY) for Q1 FY27.

Key figure: Net profit ₹24.7 Cr · +180.7% YoY

Open full results → Read the filing ↗

28 May 2026 20:02 IST BSE

Financial Results

Ind-Swift Laboratories Q4 FY26 Results: Net Profit ₹15.1 Cr, Down 93.2% YoY

Ind-Swift Laboratories Ltd reported revenue from operations of ₹169.8 Cr (+19.2% YoY) and net profit of ₹15.1 Cr (-93.2% YoY) for Q4 FY26.

Key figure: Net profit ₹15.1 Cr · -93.2% YoY

Open full results → Read the filing ↗

28 May 2026 20:01 IST BSE

Financial Results

Ind-Swift Laboratories Financial Results

Ind-Swift Laboratories approved its FY26 audited financial results and re-appointed V. Kumar & Associates as cost auditors. Performance reflects full-year operations post-amalgamation with Ind Swift Limited.

Read the filing ↗